2009 © Institute for Molecular Medicine Finland FIMM
FIMM-EMBL Group Leaders
- Dr. Kuznetsov’s research group at FIMM will focus on understanding the molecular mechanisms of breast cancer progression.
- Dr. Verschuren’s research group at FIMM will dissect cellular and biochemical properties of candidate tumor suppressors and oncogenes, aiming to build the molecular constituents of novel cancer networks.
- Dr. Wennerberg's research group at FIMM uses chemical biology and drug discovery approaches to gain new understanding of mitotic, signaling and metabolic events in cancers.
- Dr. Kainov's research group will focus on influenza A viruses, which cause recurrent outbreaks with severe consequences for human health and global economy, merging traditional biochemical and biophysical approaches with high-throughput siRNA and compound screening techniques.
Scientific Highlights
- The 1000 Genomes Project Releases Data from Pilot Studies (22.07.2010)
- Growth Curve Analyses of Finnish Population Cohorts Shed Light on the Complex Genetic Regulation of Growth in Height (16.04.2010)
- The new Finnish Gene Atlas places Finns on the world’s genetic map (17.03.2010)
- GeneSapiens - a catalogue of expression of all human genes (23.06.2009)
- Population cohort study finds six genetic variants associated with 'bad' cholesterol (in Finnish) (27.04.2009)
- All news articles
News
- Professor Juni Palmgren selected FiDiPro at FIMM (22.06.2010)
- The Nordic EMBL Partnership for Molecular Medicine officially inaugurates the Institute for Molecular Medicine Finland in Helsinki (17.03.2010)
- FIMM Annual Report 2009 (16.03.2010)
- Condolences for Leena Peltonen-Palotie (12.03.2010)
- Obituary: Professor Leena Peltonen-Palotie, Academician of Science (11.03.2010)
- All news articles